Blinatumomab Bridging Therapy for BALL

Clinical trial NCT04556084 · TERMINATED

Trial details

NCT number: NCT04556084
Sponsor: Michael Burke
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia Refractory B Acute Lymphoblastic Leukemia Relapsed B-cell Acute Lymphoblastic Leukemia

Start date: 2021-01-01
Primary completion: 2022-10-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.